Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

41.60
Delayed Data
As of Jan 13
 -0.24 / -0.57%
Today’s Change
31.38
Today|||52-Week Range
83.42
+11.11%
Year-to-Date
The Medicines Co LDL-Lowering Drug Positive in Phase II
Jan 09 / Zacks.com - Paid Partner Content
Here's Why Alnylam Pharmaceuticals Plunged 59.8% in 2016
Jan 07 / MotleyFool.com - Paid Partner Content